{"id":"https://openalex.org/W3144584180","doi":"https://doi.org/10.1016/j.ajo.2021.03.017","title":"Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis","display_name":"Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis","publication_year":2021,"publication_date":"2021-03-25","ids":{"openalex":"https://openalex.org/W3144584180","doi":"https://doi.org/10.1016/j.ajo.2021.03.017","mag":"3144584180","pmid":"https://pubmed.ncbi.nlm.nih.gov/33773984"},"language":"en","primary_location":{"id":"doi:10.1016/j.ajo.2021.03.017","doi":"https://doi.org/10.1016/j.ajo.2021.03.017","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ajo.2021.03.017","pdf_url":null,"source":{"id":"https://openalex.org/S50016660","display_name":"American Journal of Ophthalmology","issn_l":"0002-9394","issn":["0002-9394","1879-1891"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.ajo.2021.03.017","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002033864","display_name":"Eugene B. McLaurin","orcid":"https://orcid.org/0000-0002-5437-5903","observed_orcids":["https://orcid.org/0000-0002-5437-5903"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eugene B. McLaurin","raw_affiliation_strings":["From the Total Eye Care, PA (E.B.M., D.E.), Memphis, Tennessee 38119, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Total Eye Care, PA (E.B.M., D.E.), Memphis, Tennessee 38119, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Evans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Evans","raw_affiliation_strings":["From the Total Eye Care, PA (E.B.M., D.E.), Memphis, Tennessee 38119, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Total Eye Care, PA (E.B.M., D.E.), Memphis, Tennessee 38119, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081675481","display_name":"Carolyn S. Repke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163291","display_name":"Philadelphia Eye Associates","ror":"https://ror.org/05157de90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210163291"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolyn S. Repke","raw_affiliation_strings":["Philadelphia Eye Associates (C.S.R.), Philadelphia, Pennsylvania 19148, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Philadelphia Eye Associates (C.S.R.), Philadelphia, Pennsylvania 19148, USA","institution_ids":["https://openalex.org/I4210163291"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006604133","display_name":"Michelle A. Sato","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle A. Sato","raw_affiliation_strings":["East West Eye Institute (M.A.S.), Gardena, California 90247, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"East West Eye Institute (M.A.S.), Gardena, California 90247, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085096603","display_name":"Paul J Gomes","orcid":"https://orcid.org/0000-0002-1421-0186","observed_orcids":["https://orcid.org/0000-0002-1421-0186"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul J. Gomes","raw_affiliation_strings":["Ora, Inc. (P.J.G.), Andover, Massachusetts 01810, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ora, Inc. (P.J.G.), Andover, Massachusetts 01810, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103082570","display_name":"Erin Reilly","orcid":"https://orcid.org/0000-0003-1343-6439","observed_orcids":["https://orcid.org/0000-0003-1343-6439"]},"institutions":[{"id":"https://openalex.org/I4405272389","display_name":"Ocular Therapeutix, Inc. (United States)","ror":"https://ror.org/043tf0109","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272389"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin Reilly","raw_affiliation_strings":["Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA"],"raw_orcid":"https://orcid.org/0000-0003-1343-6439","affiliations":[{"raw_affiliation_string":"Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA","institution_ids":["https://openalex.org/I4405272389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043258736","display_name":"Nysha Blender","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405272389","display_name":"Ocular Therapeutix, Inc. (United States)","ror":"https://ror.org/043tf0109","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272389"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nysha Blender","raw_affiliation_strings":["Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA","institution_ids":["https://openalex.org/I4405272389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008785020","display_name":"Fabiana Queiroga de Paula Araujo Silva","orcid":"https://orcid.org/0000-0002-2402-6374","observed_orcids":["https://orcid.org/0000-0002-2402-6374"]},"institutions":[{"id":"https://openalex.org/I4405272389","display_name":"Ocular Therapeutix, Inc. (United States)","ror":"https://ror.org/043tf0109","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272389"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fabiana Q. Silva","raw_affiliation_strings":["Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA","institution_ids":["https://openalex.org/I4405272389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059912336","display_name":"Srilatha Vantipalli","orcid":"https://orcid.org/0000-0002-4108-5149","observed_orcids":["https://orcid.org/0000-0002-4108-5149"]},"institutions":[{"id":"https://openalex.org/I4405272389","display_name":"Ocular Therapeutix, Inc. (United States)","ror":"https://ror.org/043tf0109","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272389"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srilatha Vantipalli","raw_affiliation_strings":["Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA","institution_ids":["https://openalex.org/I4405272389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011723459","display_name":"Jamie Lynne Metzinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405272389","display_name":"Ocular Therapeutix, Inc. (United States)","ror":"https://ror.org/043tf0109","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272389"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jamie L. Metzinger","raw_affiliation_strings":["Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA. Electronic address: JHart@ocutx.com","Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA. Electronic address: JHart@ocutx.com","institution_ids":["https://openalex.org/I4405272389"]},{"raw_affiliation_string":"Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA","institution_ids":["https://openalex.org/I4405272389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090838299","display_name":"Andrea Gibson","orcid":"https://orcid.org/0000-0002-1655-6973","observed_orcids":["https://orcid.org/0000-0002-1655-6973"]},"institutions":[{"id":"https://openalex.org/I4405272389","display_name":"Ocular Therapeutix, Inc. (United States)","ror":"https://ror.org/043tf0109","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272389"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea Gibson","raw_affiliation_strings":["Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA","institution_ids":["https://openalex.org/I4405272389"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073617035","display_name":"Michael H. Goldstein","orcid":"https://orcid.org/0000-0001-6672-3752","observed_orcids":["https://orcid.org/0000-0001-6672-3752"]},"institutions":[{"id":"https://openalex.org/I4405272389","display_name":"Ocular Therapeutix, Inc. (United States)","ror":"https://ror.org/043tf0109","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272389"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael H. Goldstein","raw_affiliation_strings":["Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ocular Therapeutix, Inc. (E.R., N.B., F.Q.S., S.V., J.L.M., A.G., M.H.G.), Bedford, Massachusetts 01730, USA","institution_ids":["https://openalex.org/I4405272389"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5011723459"],"corresponding_institution_ids":["https://openalex.org/I4405272389"],"apc_list":{"value":3600,"currency":"USD","value_usd":3600},"apc_paid":{"value":3600,"currency":"USD","value_usd":3600},"fwci":2.5149,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.88462363,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"229","issue":null,"first_page":"288","last_page":"300"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10877","display_name":"Allergic Rhinitis and Sensitization","score":0.67330002784729,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10877","display_name":"Allergic Rhinitis and Sensitization","score":0.67330002784729,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.23549999296665192,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.033799998462200165,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allergic-conjunctivitis","display_name":"allergic conjunctivitis","score":0.9729999899864197},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9909999966621399},{"id":"https://openalex.org/keywords/ocular-itching","display_name":"ocular itching","score":0.8870000243186951},{"id":"https://openalex.org/keywords/conjunctival-hyperemia","display_name":"conjunctival hyperemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/conjunctival-allergen-challenge","display_name":"conjunctival allergen challenge","score":0.9679999947547913},{"id":"https://openalex.org/keywords/ocular-corticosteroids","display_name":"ocular corticosteroids","score":0.6779999732971191},{"id":"https://openalex.org/keywords/intraocular-pressure","display_name":"intraocular pressure","score":0.8180000185966492}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9097106456756592},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.8469620943069458},{"id":"https://openalex.org/C2779923671","wikidata":"https://www.wikidata.org/wiki/Q199602","display_name":"Itching","level":2,"score":0.8347955942153931},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8221954107284546},{"id":"https://openalex.org/C2780870513","wikidata":"https://www.wikidata.org/wiki/Q471521","display_name":"Allergic conjunctivitis","level":3,"score":0.7175320982933044},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6359489560127258},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.5051262974739075},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.47103267908096313},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.44035714864730835},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.4325408637523651},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.3981550633907318},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3871731758117676},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.38318610191345215},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3436092734336853},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25764304399490356},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.08988326787948608},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06754633784294128},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000485","descriptor_name":"Allergens","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003233","descriptor_name":"Conjunctivitis, Allergic","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D003233","descriptor_name":"Conjunctivitis, Allergic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ajo.2021.03.017","doi":"https://doi.org/10.1016/j.ajo.2021.03.017","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ajo.2021.03.017","pdf_url":null,"source":{"id":"https://openalex.org/S50016660","display_name":"American Journal of Ophthalmology","issn_l":"0002-9394","issn":["0002-9394","1879-1891"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Ophthalmology","raw_type":"journal-article"},{"id":"pmid:33773984","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33773984","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of ophthalmology","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1016/j.ajo.2021.03.017","doi":"https://doi.org/10.1016/j.ajo.2021.03.017","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ajo.2021.03.017","pdf_url":null,"source":{"id":"https://openalex.org/S50016660","display_name":"American Journal of Ophthalmology","issn_l":"0002-9394","issn":["0002-9394","1879-1891"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Ophthalmology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W72396897","https://openalex.org/W140961806","https://openalex.org/W824030939","https://openalex.org/W1156941296","https://openalex.org/W1551587560","https://openalex.org/W1725591216","https://openalex.org/W1842399002","https://openalex.org/W1971651350","https://openalex.org/W2029298225","https://openalex.org/W2041930305","https://openalex.org/W2042209176","https://openalex.org/W2052459475","https://openalex.org/W2053653136","https://openalex.org/W2058679566","https://openalex.org/W2063943641","https://openalex.org/W2072702571","https://openalex.org/W2081781694","https://openalex.org/W2088942574","https://openalex.org/W2129448112","https://openalex.org/W2135432665","https://openalex.org/W2145757872","https://openalex.org/W2150853621","https://openalex.org/W2162316179","https://openalex.org/W2167734079","https://openalex.org/W2184301013","https://openalex.org/W2185525109","https://openalex.org/W2197843009","https://openalex.org/W2273955457","https://openalex.org/W2331608000","https://openalex.org/W2335370700","https://openalex.org/W2344453828","https://openalex.org/W2490100672","https://openalex.org/W2523176172","https://openalex.org/W2579423782","https://openalex.org/W2796658020","https://openalex.org/W2884379283","https://openalex.org/W2898216747","https://openalex.org/W2903826079","https://openalex.org/W2975769986","https://openalex.org/W2983332456","https://openalex.org/W3037661227","https://openalex.org/W4251408470","https://openalex.org/W7073777643","https://openalex.org/W7075601491"],"related_works":["https://openalex.org/W4402711544","https://openalex.org/W2622725670","https://openalex.org/W2579423782","https://openalex.org/W7018767488","https://openalex.org/W4391816227","https://openalex.org/W1659444590","https://openalex.org/W4323804823","https://openalex.org/W2898216747","https://openalex.org/W792245474","https://openalex.org/W3037661227"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1],"purpose":[2],"of":[3,13,22,61,76,106,206,248],"this":[4,233],"study":[5,234],"was":[6],"to":[7,42,245,253],"evaluate":[8],"the":[9,20,62,131,236],"efficacy":[10,95],"and":[11,54,88,112,117,124,161,167,171,199,204],"safety":[12,265],"a":[14,44,48,58,74,239,263],"dexamethasone":[15,45,134,155,242],"intracanalicular":[16,243],"ocular":[17,107,141,249],"insert":[18,46,50,244],"for":[19,238,251],"treatment":[21],"allergic":[23,37,259],"conjunctivitis.":[24],"DESIGN:":[25],"Multicenter,":[26],"randomized,":[27],"double-masked,":[28],"placebo-controlled,":[29],"Phase":[30],"3":[31],"clinical":[32],"trial.":[33],"METHODS:":[34],"Subjects":[35],"with":[36,152,258],"conjunctivitis":[38],"were":[39,55,70,82,102,215],"randomized":[40],"1:1":[41],"receive":[43],"or":[47,187],"placebo":[49,145,158],"in":[51,72,226,232,256],"both":[52,227],"eyes":[53],"evaluated":[56],"using":[57],"modified":[59],"version":[60],"conjunctival":[63,119,175,200],"allergen":[64],"challenge":[65],"(CAC)":[66],"model.":[67],"After":[68],"inserts":[69,135,156],"placed":[71],"office,":[73],"series":[75],"4":[77,89,254],"closely":[78],"spaced":[79],"post-insertion":[80],"CACs":[81],"conducted":[83],"at":[84,98,109,121,146,164,178,185,202],"weeks":[85,255],"1,":[86],"2,":[87],"across":[90],"approximately":[91],"30":[92],"days.":[93],"Primary":[94],"endpoints,":[96,133],"assessed":[97],"week-1":[99],"CAC-day":[100],"8,":[101],"reported":[103],"by":[104],"subjects":[105,257],"itching":[108,142,198,250],"3,":[110,165],"5,":[111,166],"7":[113,168,186],"minutes":[114,126,180,189],"post":[115,127],"CAC":[116],"investigator-evaluated":[118],"redness":[120,176,201],"7,":[122],"15,":[123],"20":[125,179],"CAC.":[128],"RESULTS:":[129],"For":[130],"primary":[132],"showed":[136,194],"statistically":[137,172,195],"significantly":[138,173,196],"lower":[139,174],"mean":[140],"scores":[143,177],"than":[144],"all":[147],"time":[148,209],"points":[149],"(P":[150,181,190,212],"<.001),":[151],"differences":[153],"favoring":[154],"over":[157],"(0.86,":[159],"0.98,":[160],"0.96":[162],"units":[163],"minutes,":[169],"respectively)":[170],"<.05)":[182],"but":[183],"not":[184],"15":[188],"\u2265.05).":[191],"Results":[192],"also":[193],"less":[197],"31":[203],"29":[205],"33":[207],"other":[208],"points,":[210],"respectively":[211],"<.05).":[213],"There":[214],"no":[216],"serious":[217],"adverse":[218],"events;":[219],"1":[220],"subject":[221],"had":[222],"elevated":[223],"intraocular":[224],"pressure":[225],"eyes.":[228],"CONCLUSIONS:":[229],"Data":[230],"presented":[231],"demonstrate":[235],"potential":[237],"single,":[240],"physician-administered":[241],"provide":[246],"relief":[247],"up":[252],"conjunctivitis,":[260],"while":[261],"maintaining":[262],"favorable":[264],"profile.":[266]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-04-13T00:00:00"}